InMode (NASDAQ:INMD) Updates Q4 2020 Pre-Market Earnings Guidance


Share on StockTwits

InMode (NASDAQ:INMD) updated its fourth quarter 2020
Pre-Market earnings guidance on Tuesday. The company provided EPS guidance of 0.91-0.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.62. The company issued revenue guidance of $74.5-75 million, compared to the consensus revenue estimate of $63.72 million.InMode also updated its FY 2020
Pre-Market guidance to 2.08-2.10 EPS.

Several analysts have recently commented on the stock. Robert W. Baird raised their price objective on shares of InMode from $43.00 to $55.00 and gave the company an outperform rating in a research report on Tuesday, October 13th. They noted that the move was a valuation call. ValuEngine downgraded shares of InMode from a buy rating to a hold rating in a research report on Monday, November 23rd. UBS Group lifted their price target on shares of InMode from $43.00 to $47.00 and gave the company a buy rating in a report on Wednesday, October 14th. BidaskClub downgraded shares of InMode from a strong-buy rating to a buy rating in a report on Thursday, December 31st. Finally, Canaccord Genuity lifted their price target on shares of InMode from $42.00 to $51.00 and gave the company a buy rating in a report on Wednesday, October 21st. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of Buy and a consensus target price of $48.00.

Shares of NASDAQ:INMD opened at $55.22 on Thursday. InMode has a 52 week low of $13.14 and a 52 week high of $55.37. The stock has a market capitalization of $1.77 billion, a P/E ratio of 39.73 and a beta of 1.96. The firm has a fifty day simple moving average of $46.14 and a two-hundred day simple moving average of $38.02.

InMode (NASDAQ:INMD) last issued its quarterly earnings data on Thursday, November 12th. The healthcare company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.15. InMode had a net margin of 32.57% and a return on equity of 28.56%. The business had revenue of $59.70 million during the quarter, compared to analysts’ expectations of $52.62 million. During the same period last year, the company posted $0.42 EPS. The business’s revenue was up 49.3% on a year-over-year basis. On average, equities research analysts forecast that InMode will post 1.48 earnings per share for the current year.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments.

See Also: What does an outperform rating mean?

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.